We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

375 hedge funds and large institutions have $6.87B invested in Edwards Lifesciences in 2013 Q2 according to their latest regulatory filings, with 375 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

543.89% more ownership

Funds ownership: 0% → 543.89% (+544%)

137% more call options, than puts

Call options by funds: $130M | Put options by funds: $54.7M

Holders
375
Holders Change
+375
Holders Change %
–
% of All Funds
12.24%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
375
Increased
–
Reduced
–
Closed
–
Calls
$130M
Puts
$54.7M
Net Calls
+$74.8M
Net Calls Change
+$74.8M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NES
376
New England Securities
New York
– +$213 +18 New
12 13 14 15
16

EW Hedge Fund Activity: Q2 2013 in Review

375 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2013, worth a combined $6.87B.

Buyers outnumbered sellers: 375 funds opened new EW positions and 0 closed out — a net gain of 375 holders — while 0 added to existing stakes and 0 trimmed.

  • 375 institutional investors held Edwards Lifesciences (EW) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $6.87B of Edwards Lifesciences stock for Q2 2013.
  • 375 funds opened new Edwards Lifesciences positions in Q2 2013 and 0 closed out, a net change of +375 holders.

Based on aggregated 13F filings for Q2 2013.